REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 135 filers reported holding REVOLUTION MEDICINES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,103,546 | -4.4% | 473,394 | -7.6% | 4.08% | +8.8% |
| Q2 2023 | $13,703,624 | +9.9% | 512,285 | -11.0% | 3.75% | +0.2% |
| Q1 2023 | $12,471,503 | +9.6% | 575,785 | +20.5% | 3.74% | +16.7% |
| Q4 2022 | $11,380,839 | +20.3% | 477,785 | -0.4% | 3.20% | +25.9% |
| Q3 2022 | $9,461,000 | +61.9% | 479,785 | +60.0% | 2.54% | +59.8% |
| Q2 2022 | $5,843,000 | -1.3% | 299,785 | +29.2% | 1.59% | +3.2% |
| Q1 2022 | $5,921,000 | +10.8% | 232,101 | +9.4% | 1.54% | +14.9% |
| Q4 2021 | $5,342,000 | -7.4% | 212,231 | +1.2% | 1.34% | -12.3% |
| Q3 2021 | $5,770,000 | -13.3% | 209,731 | 0.0% | 1.53% | +10.0% |
| Q2 2021 | $6,657,000 | -4.1% | 209,731 | +38.7% | 1.39% | -15.4% |
| Q1 2021 | $6,938,000 | +678.7% | 151,231 | +572.1% | 1.65% | +521.1% |
| Q4 2020 | $891,000 | – | 22,500 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |